1
|
Perz JF, Armstrong GL, Farrington LA,
Hutin YJ and Bell BP: The contributions of hepatitis B virus and
hepatitis C virus infections to cirrhosis and primary liver cancer
worldwide. J Hepatol. 45:529–538. 2006. View Article : Google Scholar : PubMed/NCBI
|
2
|
Lei X, Li YF, Chen GD, Ou DP, Qiu XX, Zuo
CH and Yang LY: Ack1 overexpression promotes metastasis and
indicates poor prognosis of hepatocellular carcinoma. Oncotarget.
6:40622–40641. 2015.PubMed/NCBI
|
3
|
Salicioni AM, Xi M, Vanderveer LA, Balsara
B, Testa JR, Dunbrack RL Jr and Godwin AK: Identification and
structural analysis of human RBM8A and RBM8B: Two highly conserved
RNA-binding motif proteins that interact with OVCA1, a candidate
tumor suppressor. Genomics. 69:54–62. 2000. View Article : Google Scholar : PubMed/NCBI
|
4
|
Bechara EG, Sebestyén E, Bernardis I,
Eyras E and Valcárcel J: RBM5, 6, and 10 differentially regulate
NUMB alternative splicing to control cancer cell proliferation. Mol
Cell. 52:720–733. 2013. View Article : Google Scholar : PubMed/NCBI
|
5
|
Boman K, Segersten U, Ahlgren G, Eberhard
J, Uhlén M, Jirström K and Malmström PU: Decreased expression of
RNA-binding motif protein 3 correlates with tumour progression and
poor prognosis in urothelial bladder cancer. BMC Urol. 13:172013.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Ehlén A, Brennan DJ, Nodin B, O'Connor DP,
Eberhard J, Alvarado-Kristensson M, Jeffrey IB, Manjer J,
Brändstedt J, Uhlén M, et al: Expression of the RNA-binding protein
RBM3 is associated with a favourable prognosis and cisplatin
sensitivity in epithelial ovarian cancer. J Transl Med. 8:782010.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Fushimi K, Ray P, Kar A, Wang L,
Sutherland LC and Wu JY: Up-regulation of the proapoptotic caspase
2 splicing isoform by a candidate tumor suppressor, RBM5. Proc Natl
Acad Sci USA. 105:15708–15713. 2008. View Article : Google Scholar : PubMed/NCBI
|
8
|
Jögi A, Brennan DJ, Rydén L, Magnusson K,
Fernö M, Stål O, Borgquist S, Uhlen M, Landberg G, Påhlman S, et
al: Nuclear expression of the RNA-binding protein RBM3 is
associated with an improved clinical outcome in breast cancer. Mod
Pathol. 22:1564–1574. 2009. View Article : Google Scholar : PubMed/NCBI
|
9
|
Ishigaki Y, Nakamura Y, Tatsuno T,
Hashimoto M, Shimasaki T, Iwabuchi K and Tomosugi N: Depletion of
RNA-binding protein RBM8A (Y14) causes cell cycle deficiency and
apoptosis in human cells. Exp Biol Med (Maywood). 238:889–897.
2013. View Article : Google Scholar : PubMed/NCBI
|
10
|
Michelle L, Cloutier A, Toutant J, Shkreta
L, Thibault P, Durand M, Garneau D, Gendron D, Lapointe E, Couture
S, et al: Proteins associated with the exon junction complex also
control the alternative splicing of apoptotic regulators. Mol Cell
Biol. 32:954–967. 2012. View Article : Google Scholar : PubMed/NCBI
|
11
|
Sudo H, Tsuji AB, Sugyo A, Kohda M, Sogawa
C, Yoshida C, Harada YN, Hino O and Saga T: Knockdown of COPA,
identified by loss-of-function screen, induces apoptosis and
suppresses tumor growth in mesothelioma mouse model. Genomics.
95:210–216. 2010. View Article : Google Scholar : PubMed/NCBI
|
12
|
Zindy PJ, L'Helgoualc'h A, Bonnier D, Le
Béchec A, Bourd-Boitin K, Zhang CX, Musso O, Glaise D, Troadec MB,
Loréal O, et al: Upregulation of the tumor suppressor gene menin in
hepatocellular carcinomas and its significance in fibrogenesis.
Hepatology. 44:1296–1307. 2006. View Article : Google Scholar : PubMed/NCBI
|
13
|
Li Y, Tian B, Yang J, Zhao L, Wu X, Ye SL,
Liu YK and Tang ZY: Stepwise metastatic human hepatocellular
carcinoma cell model system with multiple metastatic potentials
established through consecutive in vivo selection and studies on
metastatic characteristics. J Cancer Res Clin Oncol. 130:460–468.
2004. View Article : Google Scholar : PubMed/NCBI
|
14
|
Maderazo AB, Belk JP, He F and Jacobson A:
Nonsense-containing mRNAs that accumulate in the absence of a
functional nonsense-mediated mRNA decay pathway are destabilized
rapidly upon its restitution. Mol Cell Biol. 23:842–851. 2003.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Chuang TW, Chang WL, Lee KM and Tarn WY:
The RNA-binding protein Y14 inhibits mRNA decapping and modulates
processing body formation. Mol Biol Cell. 24:1–13. 2013. View Article : Google Scholar : PubMed/NCBI
|
16
|
Gehring NH, Neu-Yilik G, Schell T, Hentze
MW and Kulozik AE: Y14 and hUpf3b form an NMD-activating complex.
Mol Cell. 11:939–949. 2003. View Article : Google Scholar : PubMed/NCBI
|
17
|
Hilleren P and Parker R: mRNA surveillance
in eukaryotes: Kinetic proofreading of proper translation
termination as assessed by mRNP domain organization? RNA.
5:711–719. 1999. View Article : Google Scholar : PubMed/NCBI
|
18
|
Ishigaki Y, Nakamura Y, Tatsuno T, Ma S
and Tomosugi N: Phosphorylation status of human RNA-binding protein
8A in cells and its inhibitory regulation by Magoh. Exp Biol Med
(Maywood). 240:438–445. 2015. View Article : Google Scholar : PubMed/NCBI
|
19
|
Noensie EN and Dietz HC: A strategy for
disease gene identification through nonsense-mediated mRNA decay
inhibition. Nat Biotechnol. 19:434–439. 2001. View Article : Google Scholar : PubMed/NCBI
|
20
|
Carrasco DR, Tonon G, Huang Y, Zhang Y,
Sinha R, Feng B, Stewart JP, Zhan F, Khatry D, Protopopova M, et
al: High-resolution genomic profiles define distinct
clinico-pathogenetic subgroups of multiple myeloma patients. Cancer
Cell. 9:313–325. 2006. View Article : Google Scholar : PubMed/NCBI
|
21
|
Kim TJ, Choi JJ, Kim WY, Choi CH, Lee JW,
Bae DS, Son DS, Kim J, Park BK, Ahn G, et al: Gene expression
profiling for the prediction of lymph node metastasis in patients
with cervical cancer. Cancer Sci. 99:31–38. 2008.PubMed/NCBI
|
22
|
Knuutila S, Aalto Y, Autio K, Björkqvist
AM, El-Rifai W, Hemmer S, Huhta T, Kettunen E, Kiuru-Kuhlefelt S,
Larramendy ML, et al: DNA copy number losses in human neoplasms. Am
J Pathol. 155:683–694. 1999. View Article : Google Scholar : PubMed/NCBI
|
23
|
Togi S, Shiga K, Muromoto R, Kato M, Souma
Y, Sekine Y, Kon S, Oritani K and Matsuda T: Y14 positively
regulates TNF-α-induced NF-κB transcriptional activity via
interacting RIP1 and TRADD beyond an exon junction complex protein.
J Immunol. 191:1436–1444. 2013. View Article : Google Scholar : PubMed/NCBI
|
24
|
Ishigaki Y, Nakamura Y, Tatsuno T,
Hashimoto M, Iwabuchi K and Tomosugi N: RNA-binding protein RBM8A
(Y14) and MAGOH localize to centrosome in human A549 cells.
Histochem Cell Biol. 141:101–109. 2014. View Article : Google Scholar : PubMed/NCBI
|
25
|
Arsura M and Cavin LG: Nuclear
factor-kappaB and liver carcinogenesis. Cancer Lett. 229:157–169.
2005. View Article : Google Scholar : PubMed/NCBI
|
26
|
Calvisi DF, Ladu S, Gorden A, Farina M,
Conner EA, Lee JS, Factor VM and Thorgeirsson SS: Ubiquitous
activation of Ras and Jak/Stat pathways in human HCC.
Gastroenterology. 130:1117–1128. 2006. View Article : Google Scholar : PubMed/NCBI
|
27
|
Wang C, Cigliano A, Delogu S, Armbruster
J, Dombrowski F, Evert M, Chen X and Calvisi DF: Functional
crosstalk between AKT/mTOR and Ras/MAPK pathways in
hepatocarcinogenesis: Implications for the treatment of human liver
cancer. Cell Cycle. 12:1999–2010. 2013. View Article : Google Scholar : PubMed/NCBI
|
28
|
Ohbayashi N, Taira N, Kawakami S, Togi S,
Sato N, Ikeda O, Kamitani S, Muromoto R, Sekine Y and Matsuda T: An
RNA biding protein, Y14 interacts with and modulates STAT3
activation. Biochem Biophys Res Commun. 372:475–479. 2008.
View Article : Google Scholar : PubMed/NCBI
|
29
|
Roignant JY and Treisman JE: Exon junction
complex subunits are required to splice Drosophila MAP
kinase, a large heterochromatic gene. Cell. 143:238–250. 2010.
View Article : Google Scholar : PubMed/NCBI
|
30
|
Yang L and Baker NE: Cell cycle
withdrawal, progression, and cell survival regulation by EGFR and
its effectors in the differentiating Drosophila eye. Dev
Cell. 4:359–369. 2003. View Article : Google Scholar : PubMed/NCBI
|
31
|
Brechot C, Kremsdorf D, Soussan P, Pineau
P, Dejean A, Paterlini-Brechot P and Tiollais P: Hepatitis B virus
(HBV)-related hepatocellular carcinoma (HCC): Molecular mechanisms
and novel paradigms. Pathol Biol (Paris). 58:278–287. 2010.
View Article : Google Scholar : PubMed/NCBI
|
32
|
Xu C, Zhou W, Wang Y and Qiao L: Hepatitis
B virus-induced hepatocellular carcinoma. Cancer Lett. 345:216–222.
2014. View Article : Google Scholar : PubMed/NCBI
|
33
|
Yan T, Zhao JJ, Bi XY, Zhao H, Huang Z, Li
ZY, Zhou JG, Li Y, Li C, Cai JQ, et al: Prognosis of hepatocellular
carcinoma: A study of 832 cases. Zhonghua Zhong Liu Za Zhi.
35:54–58. 2013.(In Chinese). PubMed/NCBI
|